548 related articles for article (PubMed ID: 18656619)
1. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
2. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society.
Kitagami H; Kondo S; Hirano S; Kawakami H; Egawa S; Tanaka M
Pancreas; 2007 Jul; 35(1):42-6. PubMed ID: 17575544
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
6. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
7. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors influencing results of the surgical treatment of pancreatic cancer].
Ignashov AM; Kokhanenko NIu; Lisochkin BG; Savrasov VM; Volkov ON; Dvorakovskaia IV; Lebedev EG; Kulikov IuV
Vestn Khir Im I I Grek; 2001; 160(1):33-6. PubMed ID: 11258321
[TBL] [Abstract][Full Text] [Related]
9. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).
Cress RD; Yin D; Clarke L; Bold R; Holly EA
Cancer Causes Control; 2006 May; 17(4):403-9. PubMed ID: 16596292
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
[TBL] [Abstract][Full Text] [Related]
11. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
13. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?
Hartwig W; Denneberg M; Bergmann F; Hackert T; Hinz U; Strobel O; Büchler MW; Werner J
Am J Surg; 2011 Jul; 202(1):23-7. PubMed ID: 21440887
[TBL] [Abstract][Full Text] [Related]
14. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
[TBL] [Abstract][Full Text] [Related]
16. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
17. Population-based study of islet cell carcinoma.
Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
[TBL] [Abstract][Full Text] [Related]
18. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
19. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.
Hellan M; Sun CL; Artinyan A; Mojica-Manosa P; Bhatia S; Ellenhorn JD; Kim J
Pancreas; 2008 Jul; 37(1):19-24. PubMed ID: 18580439
[TBL] [Abstract][Full Text] [Related]
20. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
Nathan H; Wolfgang CL; Edil BH; Choti MA; Herman JM; Schulick RD; Cameron JL; Pawlik TM
J Surg Oncol; 2009 Feb; 99(2):87-92. PubMed ID: 19021191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
